Amphotericin B is cytotoxic at locally delivered concentrations

Clinical Orthopaedics and Related Research

Volumn 469, Issue 11, 2011, Pages 3016-3021

  Harmsen, Samuel ^a   McLaren, Alex C ^a,b   Pauken, Christine ^b   McLemore, Ryan ^a,b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b Arizona State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ANIMAL CELL; APOPTOSIS; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EXPOSURE; FIBROBLAST; IN VITRO STUDY; MICROSCOPY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

EID: 80054717663     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-1890-2     Document Type: Conference Paper

References (20)

1. WT Butler 1966 Pharmacology, toxicity, and therapeutic usefulness of amphotericin B JAMA. 195 371 375 5951895 10.1001/jama.195.5.371 1:STN:280:DyaF28%2FnslGrtw%3D%3D
2. CJ Chunn PR Starr DN Gilbert 1977 Neutrophil toxicity of amphotericin B Antimicrob Agents Chemother. 12 226 230 900919 1:CAS:528:DyaE1cXhvVY%3D
3. N Collette P van der Auwera AP Lopez C Heymans F Meunier 1989 Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate Antimicrob Agents Chemother. 33 362 368 2658785 1:STN:280:DyaL1M3ntFOkug%3D%3D
4. B Cybulska J Bolard O Seksek A Czerwinski E Borowski 1995 Identification of the structural elements of amphotericin B and other polyene macrolide antibiotics of the hepteane group influencing the ionic selectivity of the permeability pathways formed in the red cell membrane Biochim Biophys Acta. 1240 167 178 8541288 10.1016/0005-2736(95)00170-0
5. G Domingue B Ellis M Dasgupta JW Costerton 1994 Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards J Clin Microbiol. 32 2564 2568 7814499 1:CAS:528:DyaK2cXmsFSnt7s%3D
6. ® ), with commercial lipid-based formulations Int J Pharm. 267 101 112 14602388 10.1016/j.ijpharm. 2003.08.002 1:CAS:528:DC%2BD3sXosFOqtLo%3D
7. Fungizone [package insert]. Princeton, NJ: Bristol-Myers Squibb Co; 2008.
8. R Hamid Y Rotshteyn L Rabadi R Parikh P Bullock 2004 Comparison of alamar blue and MTT assays for high through-put screening Toxicol In Vitro. 18 703 710 15251189 10.1016/j.tiv.2004.03.012 1:CAS:528:DC%2BD2cXls1WlsL4%3D
9. S Hawser L Douglas 1995 Resistance of Candida albicans biofilms to antifungal agents in vitro Antimicrob Agents Chemother. 39 2128 2131 8540729 1:CAS:528:DyaK2MXnvVygt7c%3D
10. JH Healey 2010 Editorial: the imperative to authenticate cell lines Clin Orthop Relat Res. 468 3413 3414 20878283 10.1007/s11999-010-1585-0
11. N Høiby 2002 Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies J Cyst Fibros. 1 249 254 15463822 10.1016/S1569-1993(02)00104-2
12. S Isefuku CJ Joyner AH Simpson 2003 Gentamicin may have an adverse effect on osteogenesis J Orthop Trauma. 17 212 216 12621263 10.1097/00005131- 200303000-00010
13. AS Janoff LT Boni MC Popescu SR Minchey PR Cullis TD Madden T Taraschi SM Gruner E Shyamsunder MW Tate 1988 Unusual lipid structures selectively reduce the toxicity of amphotericin B Proc Natl Acad Sci U S A. 85 6122 6126 3413081 10.1073/pnas.85.16.6122 1:CAS:528:DyaL1cXlslKitLk%3D
14. P Legrand EA Romero BE Cohen J Bolard 1992 Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes Antimicrob Agents Chemother. 36 2518 2522 1489196 1:CAS:528:DyaK3sXhtFKgsA%3D%3D
15. F Marra GM Robbins BA Masri C Duncan KM Wasan EH Kwong PJ Jewesson 2001 Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans Can J Surg. 44 383 386 11603753 1:STN:280:DC%2BD3MrlslKqsw%3D%3D
16. AC McLaren 2004 Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections Clin Orthop Relat Res. 427 101 106 15552144 10.1097/01.blo.0000143554.56897.26
17. T Miclau ML Edin GE Lester RW Lindsey LE Dahners 1995 Bone toxicity of locally applied aminoglycosides J Orthop Trauma. 9 401 406 8537843 10.1097/00005131-199505000-00007 1:STN:280:DyaK287gtVejsA%3D%3D
18. R Sabra RA Branch 1990 Amphotericin B nephrotoxicity Drug Saf. 5 94 108 2182052 10.2165/00002018-199005020-00003 1:CAS:528:DyaK3cXkslSnu7o%3D
19. PI Sealy C Nguyen M Tucci H Benghuzzi JD Cleary 2009 Delivery of antifungal agents using bioactive and nonbioactive bone cements Ann Pharmacother. 43 1606 1615 19755620 10.1345/aph.1M143 1:CAS:528: DC%2BC3cXmtlWnsrk%3D
20. P Tancréde J Barwicz S Jutras I Gruda 1990 The effect of surfactants on the aggregation state of amphotericin B Biochim Biophys Acta. 1030 289 295 2261490 10.1016/0005-2736(90)90305-8